Tonix Pharma (TNXP) Misses Q4 EPS by 79c
Tweet
Share
E-mailGet Alerts TNXP Hot Sheet
Join SI Premium – FREE
Tonix Pharma (NASDAQ: TNXP) reported Q4 EPS of ($3.98), $0.79 worse than the analyst estimate of ($3.19). Revenue for the quarter came in at $5.39 million versus the consensus estimate of $2.88 million.
For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- General Mills (GIS) Tops Q1 EPS by 3c
- AutoZone (AZO) PT Lowered to $3,700 at Raymond James
- Surf Air Mobility signs second OperatorOS deal with SkyDance Air
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
